Ctc Alternative Strategies, Ltd. Stereotaxis, Inc. Transaction History
Ctc Alternative Strategies, Ltd.
- $160 Billion
- Q1 2024
A detailed history of Ctc Alternative Strategies, Ltd. transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Ctc Alternative Strategies, Ltd. holds 16,600 shares of STXS stock, worth $34,196. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,600Holding current value
$34,196% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding STXS
# of Institutions
87Shares Held
41.5MCall Options Held
86.5KPut Options Held
43.2K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$28.2 Million8.6% of portfolio
-
Lagoda Investment Management, L.P. New York, NY3.83MShares$7.88 Million6.2% of portfolio
-
Redmile Group, LLC San Francisco, CA3.31MShares$6.82 Million0.34% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.76MShares$5.68 Million11.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.61MShares$5.38 Million0.0% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $154M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...